Chemoinformaics analysis of Stigmasta-5,22-dien-3beta-ol, Acetate
| Molecular Weight | 454.739 | nRot | 6 |
| Heavy Atom Molecular Weight | 404.339 | nRig | 22 |
| Exact Molecular Weight | 454.381 | nRing | 4 |
| Solubility: LogS | -7.111 | nHRing | 0 |
| Solubility: LogP | 7.746 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 86.7137 |
| nHD | 0 | BPOL | 52.7644 |
| QED | 0.297 |
| Synth | 4.602 |
| Natural Product Likeliness | 2.613 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.445 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.657 |
| MDCK | 0.0000077 |
| BBB | 0.473 |
| PPB | 0.98366 |
| VDSS | 2.64 |
| FU | 0.0167069 |
| CYP1A2-inh | 0.026 |
| CYP1A2-sub | 0.377 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.934 |
| CYP2c9-inh | 0.092 |
| CYP2c9-sub | 0.142 |
| CYP2d6-inh | 0.058 |
| CYP2d6-sub | 0.535 |
| CYP3a4-inh | 0.355 |
| CYP3a4-sub | 0.753 |
| CL | 7.854 |
| T12 | 0.012 |
| hERG | 0.008 |
| Ames | 0.025 |
| ROA | 0.024 |
| SkinSen | 0.025 |
| Carcinogencity | 0.07 |
| EI | 0.009 |
| Respiratory | 0.345 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.648746 |